Consider whether side effects would impair safe feeding and caregiving, and plan for backup help if you proceed with a treatment that commonly causes GI symptoms
Am J Clin Nutr 8:540546
Decapeptyl (triptorelin) revenue of EUR 535.9 million was flat-to-declining, reflecting generic pricing pressure in key markets
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial Multi-receptor agonists that target the glucagon, glucose-dependent insulinotropic polypeptide (GIP), and glucagon-like peptide 1 (GLP-1) receptors may improve outcomes in type 2 diabetes because this condition is linked to hyperglycemia and obesity
Always, always check the concentration on your vial label before every single draw
Department of Integrated Biomedical Science & Soonchunhyang Institute of Medi-Bio Science (SIMS), Soonchunhyang University, 25 Bongjeong-ro Dongnam-gu, Cheonan 31151, Korea, Tel: +82-41-413-5028, Fax: +82-41-413-5006, E-mail: [email protected] Copyright 2026 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited